Stephen B. Howell
Impact in
- Oncology top 0.1%
- Metal complexes synthesis and properties
- Drug Transport and Resistance Mechanisms
- Reproductive Medicine top 0.5%
- Ovarian cancer diagnosis and treatment
Papers in
- Co-authors
- Roohangiz SafaeiAlison K. HolzerXinjian LinPaul A. AndrewsGoli SamimiDaniel FinkKuniyuki KatanoChristopher Larson
- Journals
- Molecular Pharmacology (26 papers)Cancer Chemotherapy and Pharmacology (19 papers)Journal of Clinical Oncology (19 papers)Blood (12 papers)Clinical Cancer Research (11 papers)
- Partner nations
- United StatesJapanChina
In The Last Decade
Stephen B. Howell
329 papers receiving 17.0k citations
Hit Papers
Peers
Comparison fields: 5 of 169
- Oncology 7.9k
- Reproductive Medicine 1.4k
- Pathology and Forensic Medicine 2.6k
- Nutrition and Dietetics 2.1k
- Otorhinolaryngology 587
Countries citing papers authored by Stephen B. Howell
This map shows the geographic impact of Stephen B. Howell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen B. Howell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen B. Howell more than expected).
Fields of papers citing papers by Stephen B. Howell
This network shows the impact of papers produced by Stephen B. Howell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen B. Howell. The network helps show where Stephen B. Howell may publish in the future.
Co-authors
The 25 scholars most cited alongside Stephen B. Howell, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2022 | 1 | |
| 3 | 2022 | 6 | |
| 4 | 2018 | 13 | |
| 5 | 2018 | 68 | |
| 6 | Direct Imaging of Near Earth Object 3200 Phaethon (1983 TB) | 2018 | 1 |
| 7 | 2017 | 1 | |
| 8 | 2017 | 2 | |
| 9 | 2017 | 2 | |
| 10 | 2012 | 41 | |
| 11 | KEPLER Mission Status | 2007 | 2 |
| 12 | 2006 | 112 | |
| 13 | Cisplatin resistance is associated with reduced lysosomal structures and markers in ovarian cancer cells. | 2004 | 3 |
| 14 | 2004 | 215 | |
| 15 | 2000 | 54 | |
| 16 | Novel approaches to intraperitoneal drug delivery. | 1989 | 3 |
| 17 | 1987 | 178 | |
| 18 | 1985 | 1 | |
| 19 | Phase I trials of thymosin fraction 5 and thymosin α1 | 1982 | 6 |
| 20 | Modulation of cytosine arabinoside triphosphate (ara-CTP) and trinucleotide pools in a human acute leukemia cell line (HL-60) by thymidine (dThd) and hydroxyurea (HU) | 1981 | 2 |
About Stephen B. Howell
Stephen B. Howell is a scholar working on Oncology, Genetics, Nutrition and Dietetics, Pathology and Forensic Medicine and Reproductive Medicine, having authored 335 papers that have together received 17.6k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (52 papers), Trace Elements in Health (47 papers), Metal complexes synthesis and properties (42 papers), Intraperitoneal and Appendiceal Malignancies (34 papers), DNA Repair Mechanisms (33 papers), Chronic Lymphocytic Leukemia Research (26 papers), Chemotherapy-induced organ toxicity mitigation (24 papers) and Ovarian cancer diagnosis and treatment (22 papers). The work is most often cited by research in Oncology (7.9k citations), Reproductive Medicine (1.4k citations), Pathology and Forensic Medicine (2.6k citations), Nutrition and Dietetics (2.1k citations) and Otorhinolaryngology (587 citations). Stephen B. Howell has collaborated with scholars based in United States, Japan and China. Frequent co-authors include Roohangiz Safaei, Alison K. Holzer, Xinjian Lin, Paul A. Andrews, Goli Samimi, Daniel Fink, Kuniyuki Katano, Christopher Larson, Michael J. Sailor and R D Christen. Their work appears in journals such as Molecular Pharmacology, Cancer Chemotherapy and Pharmacology, Journal of Clinical Oncology, Blood and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.